+65.3%
GSK vs VLTO
+70.6%
-5.3%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VLTO | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | +0.6% | -0.1% | +0.4% |
| 7D | +1.1% | +1.0% | +0.2% | +1.0% |
| 30D | +6.3% | +17.5% | -11.1% | +3.4% |
| 3M | +1.8% | +21.4% | -19.6% | -1.6% |
| 6M | +1.7% | +38.1% | -36.5% | -3.4% |
| YTD | +6.5% | +19.0% | -12.5% | +3.2% |
| 1Y | +9.5% | +20.7% | -11.2% | +5.7% |
| 3Y | +65.3% | +64.3% | +1.0% | +55.5% |
| All | +65.3% | +70.6% | -5.3% | +55.5% |
Cumulative growth
Daily Returns
Daily percentage return beside VLTO.
Daily Out/Under-Performance
Portfolio return minus VLTO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VLTO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VLTO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling